Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

LUMO Lumos Pharma Inc

4,34

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 01:00:00

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Lumos Pharma (NASDAQ:LUMO)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Lumos Pharma Charts.

Lumos Pharma (NASDAQ:LUMO)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Lumos Pharma Charts.

News Lumos Pharma Inc

Form 15-12G - Securities registration termination [Section 12(g)]
Montag 23 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 14 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 14 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 14 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 14 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 14 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 14 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 14 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 14 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 14 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 14 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 14 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Weitere Lumos Pharma Inc News-Artikel

Harvest Tech Achievers G...

Societe Generale Effekten

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen